Demis Hassabis outlines Isomorphic Labs to speed drug discovery
NewsBytes | April 19, 2026 11:40 PM CST
Isomorphic Labs targets 2026 drug trial
The team is aiming for its first AI-created drug trial by 2026, building on breakthroughs like AlphaFold.
With even smarter models in the works (think AlphaFold 3 and IsoDDE), they are teaming up with big pharma names like Eli Lilly and Novartis to tackle tough diseases like cancer and heart problems.
If this works out, it could totally change how new medicines are discovered, saving time, money, and maybe even lives.
READ NEXT
-
Pakistan's Mohammed Nawaz In Trouble After Failing Recreational Drug Test, PCB Set To Investigate
-
Al Nassr vs Al Ahli Live Streaming: When And Where To Watch AFC Champions League Two Semifinal?
-
'Smarter Images, Less Prompting': Open AI Launches ChatGPT Images 2.0. Check How Netizens Are Reacting
-
SRH’s Leadership Debate Intensifies As Ishan Kishan Impresses In Absence Of Pat Cummins: 'Having An Indian Captain Brings Consistency'
-
West Bengal Gears Up for High-Stakes TMC vs BJP Battle: Here's What You Should Know as 152 Seats Go to Polls in Phase 1 Tomorrow
